跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
依嘉 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Eravacycline Hydrochloride for Injection
Approved
化学药品
Eravacycline Hydrochloride for Injection
EVEREST MEDICINES (SINGAPORE) PTE. LTD.
🇨🇳 National Medical Products Administration
Approval Date
Mar 15, 2023
Approval ID
d95a5bf5db9e6770
Company
EVEREST MEDICINES (SINGAPORE) PTE. LTD.
Type
化学药品
Approval Details
Approval Id
d95a5bf5db9e6770
Approval Number
国药准字HJ20233135
Generic Name
注射用盐酸依拉环素
Generic Name En
Eravacycline Hydrochloride for Injection
Trade Name
依嘉
Drug Type
化学药品
Dosage Form
注射剂
Strength
50mg(按C₂₇H₃₁FN₄O₈计)
Reg Date
2023-03-15
Expired Date
2028-03-14
Company Name
EVEREST MEDICINES (SINGAPORE) PTE. LTD.
Production Company Name
Patheon Manufacturing Services LLC
Company Detail Path
/organization/everest-medicines-singapore-pte-ltd
Production Company Detail Path
/organization/patheon-manufacturing-services-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 15, 2023
Approval ID
d95a5bf5db9e6770
Type
化学药品
Back to NMPA Approvals